Cargando…

How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study

BACKGROUND: Many oldest-old (> 80-years) with multimorbidity and polypharmacy are at high risk of inappropriate use of medication, but we know little about whether and how GPs would deprescribe, especially in the frail oldest-old. We aimed to determine whether, how, and why Swiss GPs deprescribe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mantelli, Sophie, Jungo, Katharina Tabea, Rozsnyai, Zsofia, Reeve, Emily, Luymes, Clare H., Poortvliet, Rosalinde K. E., Chiolero, Arnaud, Rodondi, Nicolas, Gussekloo, Jacobijn, Streit, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186124/
https://www.ncbi.nlm.nih.gov/pubmed/30314468
http://dx.doi.org/10.1186/s12875-018-0856-9
_version_ 1783362816354287616
author Mantelli, Sophie
Jungo, Katharina Tabea
Rozsnyai, Zsofia
Reeve, Emily
Luymes, Clare H.
Poortvliet, Rosalinde K. E.
Chiolero, Arnaud
Rodondi, Nicolas
Gussekloo, Jacobijn
Streit, Sven
author_facet Mantelli, Sophie
Jungo, Katharina Tabea
Rozsnyai, Zsofia
Reeve, Emily
Luymes, Clare H.
Poortvliet, Rosalinde K. E.
Chiolero, Arnaud
Rodondi, Nicolas
Gussekloo, Jacobijn
Streit, Sven
author_sort Mantelli, Sophie
collection PubMed
description BACKGROUND: Many oldest-old (> 80-years) with multimorbidity and polypharmacy are at high risk of inappropriate use of medication, but we know little about whether and how GPs would deprescribe, especially in the frail oldest-old. We aimed to determine whether, how, and why Swiss GPs deprescribe for this population. METHODS: GPs took an online survey that presented case-vignettes of a frail oldest-old patient with and without history of cardiovascular disease (CVD) and asked if they would deprescribe any of seven medications. We calculated percentages of GPs willing to deprescribe at least one medication in the case with CVD and compared these with the case without CVD using paired t-tests. We also included open-ended questions to capture reasons for deprescribing and asked which factors could influence their decision to deprescribe by asking for their agreement on a 5-point-Likert-scale. RESULTS: Of the 282 GPs we invited, 157 (56%) responded: 73% were men; mean age was 56. In the case-vignette without CVD, 98% of GPs deprescribed at least one medication (usually cardiovascular preventive medications) stating it had no indication nor benefit. They would lower the dose or prescribe pain medication as needed to reduce side effects. Their response was much the same when the patient had a history of CVD. GPs reported they were influenced by ‘risk’ and ‘benefit’ of medications, ‘quality of life’, and ‘life expectancy’, and prioritized the patient’s wishes and priorities when deprescribing. CONCLUSION: Swiss GPs were willing to deprescribe cardiovascular preventive medication when it lacked indication but tended to retain pain medication. Developing tools for GPs to assist them in balancing the risks and benefits of medication in the context of patient values may improve deprescribing activities in practice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12875-018-0856-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6186124
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61861242018-10-19 How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study Mantelli, Sophie Jungo, Katharina Tabea Rozsnyai, Zsofia Reeve, Emily Luymes, Clare H. Poortvliet, Rosalinde K. E. Chiolero, Arnaud Rodondi, Nicolas Gussekloo, Jacobijn Streit, Sven BMC Fam Pract Research Article BACKGROUND: Many oldest-old (> 80-years) with multimorbidity and polypharmacy are at high risk of inappropriate use of medication, but we know little about whether and how GPs would deprescribe, especially in the frail oldest-old. We aimed to determine whether, how, and why Swiss GPs deprescribe for this population. METHODS: GPs took an online survey that presented case-vignettes of a frail oldest-old patient with and without history of cardiovascular disease (CVD) and asked if they would deprescribe any of seven medications. We calculated percentages of GPs willing to deprescribe at least one medication in the case with CVD and compared these with the case without CVD using paired t-tests. We also included open-ended questions to capture reasons for deprescribing and asked which factors could influence their decision to deprescribe by asking for their agreement on a 5-point-Likert-scale. RESULTS: Of the 282 GPs we invited, 157 (56%) responded: 73% were men; mean age was 56. In the case-vignette without CVD, 98% of GPs deprescribed at least one medication (usually cardiovascular preventive medications) stating it had no indication nor benefit. They would lower the dose or prescribe pain medication as needed to reduce side effects. Their response was much the same when the patient had a history of CVD. GPs reported they were influenced by ‘risk’ and ‘benefit’ of medications, ‘quality of life’, and ‘life expectancy’, and prioritized the patient’s wishes and priorities when deprescribing. CONCLUSION: Swiss GPs were willing to deprescribe cardiovascular preventive medication when it lacked indication but tended to retain pain medication. Developing tools for GPs to assist them in balancing the risks and benefits of medication in the context of patient values may improve deprescribing activities in practice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12875-018-0856-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-12 /pmc/articles/PMC6186124/ /pubmed/30314468 http://dx.doi.org/10.1186/s12875-018-0856-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mantelli, Sophie
Jungo, Katharina Tabea
Rozsnyai, Zsofia
Reeve, Emily
Luymes, Clare H.
Poortvliet, Rosalinde K. E.
Chiolero, Arnaud
Rodondi, Nicolas
Gussekloo, Jacobijn
Streit, Sven
How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
title How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
title_full How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
title_fullStr How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
title_full_unstemmed How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
title_short How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
title_sort how general practitioners would deprescribe in frail oldest-old with polypharmacy — the less study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186124/
https://www.ncbi.nlm.nih.gov/pubmed/30314468
http://dx.doi.org/10.1186/s12875-018-0856-9
work_keys_str_mv AT mantellisophie howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy
AT jungokatharinatabea howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy
AT rozsnyaizsofia howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy
AT reeveemily howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy
AT luymesclareh howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy
AT poortvlietrosalindeke howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy
AT chioleroarnaud howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy
AT rodondinicolas howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy
AT gussekloojacobijn howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy
AT streitsven howgeneralpractitionerswoulddeprescribeinfrailoldestoldwithpolypharmacythelessstudy